Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis
Launched by UNIVERSITY OF ZURICH · Jun 3, 2009
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease, affecting primarily the spinal column and iliosacral joints. In addition, an increased risk for cardio-vascular disease and osteoporosis has been described in patients with AS. Patients with AS may suffer from severe impairment in physical functioning, i.e. spinal stiffness, pain and fatigue, which reduces their daily activities, and quality of life. As AS mainly affects young people, work capacity may be reduced, which, together with medical treatment costs, results in a considerable burden for the society.
Current t...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Age 18-75 years
- • Diagnosis of AS following the modified New York criteria
- • Ability to cycle on a training bicycle
- • Sufficient German language ability (for questionnaires)
- • Willingness to follow the study protocol / informed consent
- Exclusion criteria:
- • Chronic heart failure, functional NYHA Class III and IV
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, Zh, Switzerland
Patients applied
Trial Officials
Heike Bischoff Ferrari, MD, MPH
Principal Investigator
University Hospital Zurich, Centre on Aging and Mobility
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials